Spectral AI (MDAI) vs TELA Bio (TELA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TELA Bio (TELA) has outperformed Spectral AI (MDAI) over the past year, losing 31.4% versus a loss of 35.2%. Over five years, MDAI leads with a -83.2% price change compared with -91.7% for TELA. Spectral AI is the larger company by market cap ($53.7 million vs $46.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDAI | TELA |
|---|---|---|
| Share price | $1.67 | $1.02 |
| Market cap | $53.75M | $46.05M |
| 1-day change | +1.83% | -2.82% |
| YTD return | +15.49% | -11.02% |
| 1-year return | -35.18% | -31.37% |
| 5-year return | -83.20% | -91.67% |
| EPS (TTM) | $-0.32 | $-0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.97 | $1.56 |
| 52-week low | $1.18 | $0.501 |
| Distance from 52-week high | -43.77% | -34.62% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +205.99% | +103.92% |
| Average volume | 150.48K | 214.83K |
| Shares outstanding | 32.18M | 45.14M |
| Employees | 65 | 218 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Spectral AI
MDAI stock →Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds.
Health Care · Medical/Dental Instruments · 65 employees
About TELA Bio
TELA stock →TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
Health Care · Medical/Dental Instruments · 218 employees
MDAI vs TELA FAQ
Which is bigger, Spectral AI or TELA Bio?
Spectral AI (MDAI) is larger, with a market capitalization of $53.75M compared with $46.05M for TELA Bio (TELA).
Which stock has performed better over the past year, MDAI or TELA?
TELA returned -31.37% over the past 12 months, compared with -35.18% for MDAI (price return, excluding dividends). Past performance does not predict future results.
Are Spectral AI and TELA Bio in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.